MedTrace Logo

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

NCT03098199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2018-04-12

No results posted yet for this study

Summary

This is a research study on a hormone in women called anti-mullerian hormone (AMH) an indicator of the amount of egg reserve in the ovaries. The research involves a blood draw to determine the AMH level. This knowledge will help the investigators decide a dosage of gonadotropins, the hormones used to stimulate the production of more than one egg for use in an in vitro fertilization (IVF) cycle. The amount of gonadotropin given has to be tailored to each individual participant. The investigators can use information about the participant and the hormone levels to determine this dosage and the chances of becoming pregnant as a result of IVF treatment. The reason the investigators are doing this research is to find out if basing the gonadotropin dosage solely on the participant's AMH level will give the investigators a better result than the previous method based on age and other hormone levels.

Conditions

Interventions

DRUG

300IU Gonal-F

\<1.5 AMH group

DRUG

150IU Menopur

\<1.5 AMH group

DRUG

225IU Gonal-F

1.6-2.5 AMH group

DRUG

75IU Menopur

1.6-2.5 AMH group 2.6-6.9 AMH group \>7.0 AMH group

DRUG

150IU Gonal-F

2.6-6.9 AMH group

DRUG

75IU Gonal-F

\>7.0 AMH group

Sponsors & Collaborators

  • Reproductive Specialists of New York

    lead OTHER

Principal Investigators

  • Linda Sung, MD · Reproductive Specialists of New York

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-22
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098199 on ClinicalTrials.gov